Hc. Matter et al., FIELD-EVALUATION OF 2 BAIT DELIVERY SYSTEMS FOR THE ORAL IMMUNIZATIONOF DOGS AGAINST RABIES IN TUNISIA, Vaccine, 16(7), 1998, pp. 657-665
Citations number
35
Categorie Soggetti
Veterinary Sciences",Immunology,"Medicine, Research & Experimental
Two bait delivery systems for the oral immunization of dogs against ra
bies were tested in small scale field trials in a semi-rural area in T
unisia: bait delivery to owned dogs during door to door visits of hous
eholds (door to door baiting) and distribution of baits on transect li
nes (transect line baiting), A prototype bait (DBL2) configured for in
dustrial production and containing either sulfadimethoxine (SDM) as a
systemic marker or Rhodamine B as a topical marker was used. The over-
all proportion of dogs which took a bait and presented topical marker-
staining after door to door baiting was 59.1%. The total time and cost
s spent per bait accepting dog averaged 34 person minutes and US$4, re
spectively. Unconsummated baits were readily recovered. No unprotected
human contacts with baits were recorded. Door to door baiting is a ve
ry specific but time-consuming method that enables a safe administrati
on of vaccine baits to owned dogs. For transect line baiting, baits we
re distributed at a density of ca 3000 baits per km(2) along double tr
ansect lines. Baits were recovered after 20 h. According to the propor
tion of SDM positive serum samples, 24.1% of owned dogs in the baiting
area had consumed baits. Of all owned and ownerless dogs, presumably
free-roaming during transect line baiting, > 40% had consumed baits. T
he total time and costs spent per bait accepting dog averaged 48 perso
n minutes and ca US$20, respectively. The household census revealed 32
direct human contacts with the bait matrix which corresponds to 1.4%
of inhabitants. Placing baits on transect lines gives the possibility
to vaccinate dogs not accessible by vaccination systems which base on
dog owner participation. However, the method is not specific, less saf
e than other systems, not easily accepted by the human population, and
costly. (C) 1998 Elsevier Science Ltd. All rights reserved.